Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

30.89

+0.21 (0.68%)

At close: May 22, 2026, 4:00 PM EDT

30.85

-0.04 (-0.13%)

After-hours: May 22, 2026, 7:59 PM EDT

Viking Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-472.34	-359.64	-109.96	-85.9	-68.87	-54.99
Depreciation & Amortization	0.41	0.43	0.35	0.29	0.29	0.3
Stock-Based Compensation	39.81	40.82	29.71	16.75	8.67	6.1
Other Adjustments	-7.46	-9.27	-17.25	-8.07	1.32	3.94
Changes in Accounts Payable	59.48	43.44	2.3	-1.02	7.09	-2.54
Changes in Accrued Expenses	27.77	6.17	5.82	-1.82	5.81	-0.51
Changes in Other Operating Activities	12.01	-0.63	1.24	6.38	-2.71	0.12
Operating Cash Flow	-340.33	-278.69	-87.79	-73.38	-48.4	-47.59
Purchases of Investments	-257.86	-418.04	-1,113	-478.3	-121.43	-168.02
Proceeds from Sale of Investments	590.19	759.43	560	299.22	176.18	205.98
Investing Cash Flow	332.33	341.39	-553.37	-179.09	54.75	37.96
Issuance of Common Stock	88.17	76.44	654.57	278.5	12.49	7.59
Repurchase of Common Stock	-	-	-42.1	-7.12	-8.33	-0.71
Net Common Stock Issued (Repurchased)	88.17	76.44	612.46	271.38	4.16	6.88
Financing Cash Flow	88.17	76.44	612.46	271.38	4.16	6.88
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.01	-0.01	-0.15	-0.03	-0.26	-
Net Cash Flow	80.17	139.14	-28.69	18.91	10.52	-2.75
Free Cash Flow	-340.33	-278.69	-87.79	-73.38	-48.4	-47.59
Free Cash Flow Per Share	-3.00	-2.47	-0.81	-0.78	-0.63	-0.62
Levered Free Cash Flow	-372.67	-310.23	-100.26	-82.06	-58.39	-57.62
Unlevered Free Cash Flow	-402.33	-343.93	-141.21	-96.99	-59.88	-58.31

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q